Navigation Links
Remedy Informatics Announces Growth Capital Investment from Merck Global Health Innovation Fund
Date:11/13/2012

SALT LAKE CITY, Nov. 13, 2012 /PRNewswire/ -- Remedy Informatics, Inc., the leader in registries for healthcare and life science research, announced today that the Merck Global Health Innovation Fund (GHIF) has made an investment of growth capital in the company. The investment of roughly $6 million includes a seat on Remedy's Board of Directors and the opportunity for additional investments in the future.

(Logo: http://photos.prnewswire.com/prnh/20120206/SF47874LOGO)

"In the past year we've experienced unprecedented demand for our registries and integrated research management systems. This additional capital will fuel our growth here in the U.S. and our expansion into Europe and Latin America," said Gary Kennedy, Founder & CEO of Remedy Informatics. "In addition it will enable us to continue to invest in our Mosaic™ Platform so that we can further extend our technology lead in the marketplace."

Remedy serves a wide range of leading life science and healthcare institutions across the globe. During the last 12 months Remedy has entered into a series of major new customer engagements, including Cleveland Clinic's Heart and Vascular Institute, Massachusetts General Hospital, Baylor Health Care System, Princess Margaret Cancer Centre in Toronto, Indiana University and the Indiana Clinical and Translational Science Institute, Genentech and many others. Remedy's Investigate™ integrated research management system provides game-changing new capabilities for researchers in translational science by integrating data flows and analytics across the lab, clinic and biobank settings. Remedy has also deployed powerful new clinical registries like ComprehensiveOncology™ (suite of solid tumor and blood cancer registries), ComprehensiveBMT™ (blood and marrow transplant registry), RemedyJoint™ (total joint replacement registry), and many others that enable tracking of patient outcomes and conducting clinical research.

"Healthcare information technology is a key area of focus for Merck's Global Health Innovation Fund," said Joe Volpe, investment principle for GHIF. "We believe Remedy's technology platform is well positioned to help advance life science research discoveries."

About Remedy Informatics, Inc.

Remedy Informatics, Inc. is the leading provider of clinical registries, medical research software, and research informatics products that accelerate translational medicine discoveries from bench to bedside. Remedy offers a wide range of configurable "off the shelf" biomedical informatics products that are built on the powerful Mosaic™ Platform. Remedy's mission is to tangibly, measurably and permanently improve the effectiveness of Life Science Research in the United States and across the globe.  For more information visit: www.remedyinformatics.com.

Available Topic Expert(s): For information on the listed expert(s), click appropriate link.
Gary Kennedy
https://profnet.prnewswire.com/Subscriber/ExpertProfile.aspx?ei=106824

Media Contacts
Kristofer Beldin, Remedy Informatics, (801) 870-9407 (cell), kris.beldin@remedyinformatics.com

 


'/>"/>
SOURCE Remedy Informatics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Remedy Informatics Joins LongView International Technology Solutions Team to Win CIO-SP3 Contract Award
2. The Jewish Hospital - Mercy Health Selects Remedy Informatics ComprehensiveBMT Product
3. Remedy Informatics to Debut SpecimenTrack, Next-Generation Biorepository Software at ISBER 2012 Annual Meeting
4. Remedy Informatics Named "Cool Vendor" in Life Sciences by Leading Technology Analyst Firm
5. Remedy Informatics Cardiovascular Registry Selected by World-Renowned Cleveland Clinic Heart and Vascular Institute
6. Frost & Sullivan: U.S. Medical Imaging Informatics Industry Reconnects with Growth in the Enterprise Image Archiving Market
7. Frost & Sullivan Acknowledges the Value Dell Healthcare and Life Sciences Brings to the Enterprise Imaging Informatics Marketplace
8. Pharma IQs Laboratory Informatics Whitepaper
9. Health Revenue Assurance Associates Hires Valerie Rinkle as Vice President of Revenue Integrity Informatics
10. Pharma IQs Laboratory Informatics Report: Current Trends & Predictions for 2015
11. RPS Announces Jonathan M. Fishbein, MD as Executive Vice President and Chief Medical Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/21/2017)... 2017 ResMed (NYSE: RMD ), BMC ( ... Haven, Florida ) today announced they have agreed on a ... will be permitted to sell their existing products in exchange for ... payment to 3B to close the Florida ... admission of liability or wrongdoing by any party. ...
(Date:1/21/2017)... , Jan. 20, 2017 ARMO BioSciences, Inc., ... data on the Company,s lead investigational immuno-oncology drug AM0010 ... by the American Society of Clinical Oncology (ASCO), taking ... CA. "AM0010 induces the ... + T cells in the blood and tumors ...
(Date:1/21/2017)... -- Research and Markets has announced the addition of ... Route Of Administration, End User - Forecast to 2025" report ... ... a CAGR of around 7.8% over the next decade to reach ... analyzes the global markets for Advanced Drug Delivery across all the ...
Breaking Medicine Technology:
(Date:1/22/2017)... TX (PRWEB) , ... January 22, 2017 , ... ... provide slow results. Often the results of a simple test will take days to ... Any Lab Test Now offers customers direct access to their lab tests, bypassing the ...
(Date:1/21/2017)... (PRWEB) , ... January 21, 2017 , ... Phytocéane ... Indian Ocean, isolated from the rest of the world with ZANZIBAR SHOWER GEL. Inspired ... Phytocéane used key ingredients, Virgin Coconut Oil and moisturizing vegetal coral to create this ...
(Date:1/21/2017)... ... January 21, 2017 , ... The Nobel ... Dan Holtzclaw in media for its creos™ line of bone regenerative products. ... Holtzclaw in which he utilizes creos™ allo.gain™ bone graft for a variety of ...
(Date:1/20/2017)... , ... January 20, 2017 , ... Doctor C LLC, ... attended the January ECRM trade show to continue the marketing and distribution of its ... supplement, known for providing 400 percent better absorption than traditional vitamin C supplements. At ...
(Date:1/20/2017)... ... January 20, 2017 , ... Michael and Betsy Brauser celebrated 5 years ... Betsy, the clinical trial has been life-saving as she has been on the ... Betsy Brauser was diagnosed with ovarian cancer in 2009. She underwent standard chemotherapy but ...
Breaking Medicine News(10 mins):